Author

C. C. Dibble

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:comparative / phylogenetic analysis· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. Simeonov· 1 shared B. A. Garcia· 1 shared C. A. LeClair· 1 shared D. Gallimore· 1 shared D. R. Tripu· 1 shared G. M. DeNicola· 1 shared J. L. Meier· 1 shared J. M. Asara· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

A. Simeonov

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Comparative analysis of drug-like EP300/CREBBP acetyltransferase inhibitors

M. C. Crawford, D. R. Tripu, S. A. Barritt, Y. Jing, D. Gallimore, S. C. Kales, N. V. Bhanu, Y. Xiong, Y. Fang, K. A. T. Butler, C. A. LeClair, N. P. Coussens, A. Simeonov, B. A. Garcia, C. C. Dibble, J. L. Meier

This study compares the biochemical and biological potencies of three EP300/CREBBP acetyltransferase inhibitors and demonstrates their utility in investigating epigenetic mechanisms.

bioRxiv · May 15, 2023Biochemistry

Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer

Y. P. Kang, L. Torrente, M. Liu, J. M. Asara, C. C. Dibble, G. M. DeNicola

The paper identifies CDO1 as a metabolic liability in NSCLC by showing its silencing promotes proliferation through cysteine metabolism disruption.

bioRxiv · Nov 1, 2018Cancer Biology